FOXP3 Subcellular Localization Predicts Recurrence in Oral Squamous Cell Carcinoma

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Weed, Donald T ^a,b   Walker, Gail ^a,b   De La Fuente, Adriana C ^a   Nazarian, Ronen ^a,b   Vella, Jennifer L ^a   Gomez Fernandez, Carmen R ^a,b   Serafini, Paolo ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR FOXP3;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CASE CONTROL STUDY; CD4+ T LYMPHOCYTE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH SQUAMOUS CELL CARCINOMA; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CELL NUCLEUS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROTEIN TRANSPORT; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; TUMOR MARKERS, BIOLOGICAL;

EID: 84882576985     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071908     Document Type: Article

References (30)

1. Toh B, Chew V, Dai X, Khoo K, Tham M, et al. (2012) Immune predictors of cancer progression. Immunol Res 53: 229-234.
2. deLeeuw RJ, Kost SE, Kakal JA, Nelson BH, (2012) The prognostic value of FoxP3+ tumor-infiltrating lymphocytes in cancer: a critical review of the literature. Clin Cancer Res 18: 3022-3029.
3. Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, et al. (2004) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10: 942-949.
4. Martin F, Ladoire S, Mignot G, Apetoh L, Ghiringhelli F, (2010) Human FOXP3 and cancer. Oncogene 29: 4121-4129.
5. Zhang YL, Li J, Mo HY, Qiu F, Zheng LM, et al. (2010) Different subsets of tumor infiltrating lymphocytes correlate with NPC progression in different ways. Mol Cancer 9: 4.
6. Distel LV, Fickenscher R, Dietel K, Hung A, Iro H, et al. (2009) Tumour infiltrating lymphocytes in squamous cell carcinoma of the oro- and hypopharynx: prognostic impact may depend on type of treatment and stage of disease. Oral Oncol 45: e167-174.
7. Pretscher D, Distel LV, Grabenbauer GG, Wittlinger M, Buettner M, et al. (2009) Distribution of immune cells in head and neck cancer: CD8+ T-cells and CD20+ B-cells in metastatic lymph nodes are associated with favourable outcome in patients with oro- and hypopharyngeal carcinoma. BMC Cancer 9: 292.
8. Badoual C, Hans S, Rodriguez J, Peyrard S, Klein C, et al. (2006) Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers. Clin Cancer Res 12: 465-472.
9. Zingg U, Montani M, Frey DM, Dirnhofer S, Esterman AJ, et al. (2010) Tumour-infiltrating lymphocytes and survival in patients with adenocarcinoma of the oesophagus. Eur J Surg Oncol 36: 670-677.
10. Morgan ME, van Bilsen JH, Bakker AM, Heemskerk B, Schilham MW, et al. (2005) Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans. Hum Immunol 66: 13-20.
11. Wang J, Ioan-Facsinay A, van der Voort EI, Huizinga TW, Toes RE, (2007) Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells. Eur J Immunol 37: 129-138.
12. Kmieciak M, Gowda M, Graham L, Godder K, Bear HD, et al. (2009) Human T cells express CD25 and Foxp3 upon activation and exhibit effector/memory phenotypes without any regulatory/suppressor function. J Transl Med 7: 89.
13. Magg T, Mannert J, Ellwart JW, Schmid I, Albert MH, (2012) Subcellular localization of FOXP3 in human regulatory and nonregulatory T cells. Eur J Immunol 42: 1627-1638.
14. Collins TJ, (2007) ImageJ for microscopy. Biotechniques 43: 25-30.
15. Kamentsky L, Jones TR, Fraser A, Bray MA, Logan DJ, et al. (2011) Improved structure, function and compatibility for CellProfiler: modular high-throughput image analysis software. Bioinformatics 27: 1179-1180.
16. Jones TR, Kang IH, Wheeler DB, Lindquist RA, Papallo A, et al. (2008) CellProfiler Analyst: data exploration and analysis software for complex image-based screens. BMC Bioinformatics 9: 482.
17. Vokes MS, Carpenter AE (2008) Using CellProfiler for automatic identification and measurement of biological objects in images. Curr Protoc Mol Biol Chapter 14: Unit 14 17.
18. Lamprecht MR, Sabatini DM, Carpenter AE, (2007) CellProfiler: free, versatile software for automated biological image analysis. Biotechniques 42: 71-75.
19. Carpenter AE, Jones TR, Lamprecht MR, Clarke C, Kang IH, et al. (2006) CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol 7: R100.
20. Duray A, Demoulin S, Hubert P, Delvenne P, Saussez S, (2010) Immune suppression in head and neck cancers: a review. Clin Dev Immunol 2010: 701657.
21. Bragelmann J, Dagogo-Jack I, El Dinali M, Stricker T, Brown CD, et al. (2013) Oral cavity tumors in younger patients show a poor prognosis and do not contain viral RNA. Oral Oncol 49: 525-533.
22. Marklund L, Nasman A, Ramqvist T, Dalianis T, Munck-Wikland E, et al. (2012) Prevalence of human papillomavirus and survival in oropharyngeal cancer other than tonsil or base of tongue cancer. Cancer Med 1: 82-88.
23. Fox BC, Bignone PA, Brown PJ, Banham AH, (2008) Defense of the clone: antibody 259D effectively labels human FOXP3 in a variety of applications. Blood 111: 3897-3899.
24. Smith EL, Finney HM, Nesbitt AM, Ramsdell F, Robinson MK, (2006) Splice variants of human FOXP3 are functional inhibitors of human CD4+ T-cell activation. Immunology 119: 203-211.
25. Mailer RK, Falk K, Rotzschke O, (2009) Absence of leucine zipper in the natural FOXP3 Delta2 Delta7 isoform does not affect dimerization but abrogates suppressive capacity. PLoS ONE 4: e6104.
26. Law JP, Hirschkorn DF, Owen RE, Biswas HH, Norris PJ, et al. (2009) The importance of Foxp3 antibody and fixation/permeabilization buffer combinations in identifying CD4+CD25+Foxp3+ regulatory T cells. Cytometry A 75: 1040-1050.
27. Woo YL, Sterling J, Crawford R, van der Burg SH, Coleman N, et al. (2008) FOXP3 immunohistochemistry on formalin-fixed paraffin-embedded tissue: poor correlation between different antibodies. J Clin Pathol 61: 969-971.
28. Sakaguchi S, Miyara M, Costantino CM, Hafler DA, (2010) FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol 10: 490-500.
29. Velez de Mendizabal N, Carneiro J, Sole RV, Goni J, Bragard J, et al. (2011) Modeling the effector- regulatory T cell cross-regulation reveals the intrinsic character of relapses in Multiple Sclerosis. BMC Syst Biol 5: 114.
30. Serafini P, Mgebroff S, Noonan K, Borrello I, (2008) Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells. Cancer Research 68: 5439-5449.